Summary
Elevance Health, Inc. (ELV), formerly Anthem Inc., filed an 8-K on July 25, 2018, to report its second-quarter financial results for the period ended June 30, 2018. The report primarily consists of a press release containing these financial results. While the filing itself doesn't contain deep operational details, it serves as an official channel to disseminate the company's quarterly performance. Investors should note that the information furnished in this 8-K is not considered 'filed' for Section 18 purposes, meaning it doesn't carry the same liability as other SEC filings, and is not automatically incorporated into future registration statements unless explicitly referenced. The press release attached (Exhibit 99.1) is the key document for understanding the quarter's performance. Investors would need to refer to that exhibit for specific figures on revenue, earnings, membership, and any guidance provided by the company. The 8-K also includes standard forward-looking statement disclaimers, highlighting the inherent risks and uncertainties associated with the company's future performance, including regulatory changes, healthcare cost trends, and competitive pressures. The extended discussion of risks underscores the volatile nature of the healthcare industry.
Key Highlights
- 1Elevance Health (Anthem Inc.) released its second-quarter 2018 financial results via an 8-K filing on July 25, 2018.
- 2The primary content of the filing is a press release detailing the company's performance for the quarter ended June 30, 2018.
- 3Information furnished in this 8-K is not considered 'filed' under Section 18 of the Securities Exchange Act of 1934, limiting liability.
- 4The filing includes standard forward-looking statements outlining potential risks and uncertainties affecting future performance.
- 5Key risks mentioned include regulatory changes (like the ACA), healthcare cost trends, provider contracting, enrollment levels, and government program performance (Medicare/Medicaid).
- 6The company also noted potential litigation risks, specifically mentioning ongoing disputes with Cigna Corporation.
- 7The filing serves as an official notification of earnings release, with detailed financial data found in the accompanying press release (Exhibit 99.1).